Abvc Biopharma (ABVC) Short-term Investments (2021 - 2026)
Abvc Biopharma's Short-term Investments came in at $55,160 for Q3 2026, down 15.4% from $65,175 a year earlier and down 11.6% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Short-term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma's Short-term Investments was $64,354, down 0.6% from FY2024.
- Short-term Investments carries a four-year compound annual growth rate of -12.2% (FY2021 to FY2025).
- Going back by year, Short-term Investments was $64,736 in FY2024 (-18.4%), $79,312 in FY2023 (+4.6%), $75,797 in FY2022 (-29.9%) and $108,147 in FY2021.
- The Q3 2026 figure represents the lowest quarterly Short-term Investments in data going back to Q3 2021.
- Year-over-year, Short-term Investments has declined for eight consecutive quarters, with an average decline of 9.9% over the last eight quarters.
- The fastest year-over-year change in Short-term Investments over five years came in Q4 2023 (growth of 4.6%), and the weakest in Q3 2022 (a decline of 30.3%).
- Business Quant data shows ABVC's Short-term Investments at $62,420 (Q2 2026), $62,185 (Q1 2026) and $64,354 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 55,160.00 |
| Jun 30, 2026 | 62,420.00 |
| Mar 31, 2026 | 62,185.00 |
| Dec 31, 2025 | 64,354.00 |
| Sep 30, 2025 | 65,175.00 |
| Jun 30, 2025 | 65,211.00 |
| Mar 31, 2025 | 65,052.00 |
| Dec 31, 2024 | 64,736.00 |
| Sep 30, 2024 | 70,809.00 |
| Jun 30, 2024 | 75,683.00 |
| Mar 31, 2024 | 75,916.00 |
| Dec 31, 2023 | 79,312.00 |
| Sep 30, 2023 | 68,521.00 |
| Jun 30, 2023 | 76,787.00 |
| Mar 31, 2023 | 78,014.00 |
| Dec 31, 2022 | 75,797.00 |
| Sep 30, 2022 | 77,583.00 |
| Jun 30, 2022 | 82,755.00 |
| Mar 31, 2022 | 95,553.00 |
| Dec 31, 2021 | 108,147.00 |
API Access
Abvc Biopharma Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();